$MIRMMirum Pharmaceuticals, Inc.

Active trials

• phase2Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)recruitingn=60
• phase2MRX-901: An Open-label Study to Assess Safety and Tolerability of Maralixibat in Participants With Intrahepatic Cholestasis of Pregnancy (ICP)not yet recruitingn=15
• phase2A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)active not recruitingn=182
• —The REPLACE Registry for Cholbam® (Cholic Acid)active not recruitingn=55
• phase2A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitisrecruitingn=260
• phase3Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtiderecruitingn=120
• phase3Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)active not recruitingn=90
• phase3A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)recruitingn=172